The price-to-earnings ratio for Alkermes plc (NASDAQ: ALKS) is above average at 15.75x, Company’s 36-month beta value is 0.37.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 2 as “overweight,” 6 as “hold,” and 1 as “sell.”
The public float for ALKS is 158.43M, and currently, short sellers hold a 8.84% ratio of that floaft. The average trading volume of ALKS on March 20, 2025 was 1.66M shares.
ALKS) stock’s latest price update
The stock of Alkermes plc (NASDAQ: ALKS) has decreased by -0.09 when compared to last closing price of 34.37. Despite this, the company has experienced a 2.78% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-08-23 that Alkermes’ (ALKS) phase II Vibrance-2 study investigates the safety and efficacy of ALKS 2680 versus placebo for treating adults with narcolepsy type 2.
ALKS’s Market Performance
Alkermes plc (ALKS) has experienced a 2.78% rise in stock performance for the past week, with a -4.35% drop in the past month, and a 12.55% rise in the past quarter. The volatility ratio for the week is 2.95%, and the volatility levels for the past 30 days are at 2.95% for ALKS. The simple moving average for the last 20 days is -0.73% for ALKS stock, with a simple moving average of 20.07% for the last 200 days.
Analysts’ Opinion of ALKS
Many brokerage firms have already submitted their reports for ALKS stocks, with RBC Capital Mkts repeating the rating for ALKS by listing it as a “Sector Perform.” The predicted price for ALKS in the upcoming period, according to RBC Capital Mkts is $40 based on the research report published on March 13, 2025 of the current year 2025.
UBS, on the other hand, stated in their research note that they expect to see ALKS reach a price target of $38, previously predicting the price at $21. The rating they have provided for ALKS stocks is “Neutral” according to the report published on March 04th, 2025.
Deutsche Bank gave a rating of “Buy” to ALKS, setting the target price at $40 in the report published on February 11th of the current year.
ALKS Trading at 5.45% from the 50-Day Moving Average
After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.79% of loss for the given period.
Volatility was left at 2.95%, however, over the last 30 days, the volatility rate increased by 2.95%, as shares sank -4.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +18.25% upper at present.
During the last 5 trading sessions, ALKS rose by +2.78%, which changed the moving average for the period of 200-days by +47.95% in comparison to the 20-day moving average, which settled at $34.59. In addition, Alkermes plc saw 19.40% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALKS starting from Parisi Samuel Joseph, who sale 1,938 shares at the price of $34.00 back on Feb 28 ’25. After this action, Parisi Samuel Joseph now owns 7,717 shares of Alkermes plc, valued at $65,892 using the latest closing price.
Parisi Samuel Joseph, the VP, Finance (Interim PAO) of Alkermes plc, sale 3,743 shares at $35.26 during a trade that took place back on Feb 25 ’25, which means that Parisi Samuel Joseph is holding 7,717 shares at $131,978 based on the most recent closing price.
Stock Fundamentals for ALKS
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.84 for the gross margin
The net margin for Alkermes plc stands at 0.24. The total capital return value is set at 0.26. Equity return is now at value 27.90, with 17.76 for asset returns.
Based on Alkermes plc (ALKS), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 5.81. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 18.63.
Currently, EBITDA for the company is 420.64 million with net debt to EBITDA at -0.46. When we switch over and look at the enterprise to sales, we see a ratio of 3.45. The receivables turnover for the company is 4.0for trailing twelve months and the total asset turnover is 0.76. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.04.
Conclusion
In a nutshell, Alkermes plc (ALKS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
